Top Markets
Coin of the day
Avivagen Inc. Avivagen Inc.

Avivagen Inc.

VIV
Rang in Aktien #40244
Avivagen Inc. is a life sciences enterprise that invents and sells specialized... Avivagen Inc. is a life sciences enterprise that invents and sells specialized products, primarily for animal feed, aimed at bolstering the immune systems of livestock. These solutions are designed to enhance animals' health, leading to improved growth and overall productivity. The company's diverse product lineup features OxC-beta Livestock, a crucial premix for farm animal diets. Beyond agriculture, Avivagen also manufactures health supplements such as Vivamune and Dr. Tobias-branded chews for dogs, along with the Dr. Tobias Beta blend, formulated to support human immunity. Established in 2005 and based in Ottawa, Canada, Avivagen Inc. distributes its offerings across numerous international markets, including the United States, Canada, the Philippines, Taiwan, Thailand, China, Mexico, Brazil, and Malaysia.
Aktienkurs
$0.00368316
Zuletzt synchronisiert: 2024-03-04
Marktkapitalisierung
$199.43K
Veränderung (1 Tag)
0.05%
Veränderung (1 Jahr)
0.00%
Land
CA
Handel Avivagen Inc. (VIV)

Kategorie

Kursverlauf für Avivagen Inc. (VIV)
Höchster Schlusskurs: $0.00 am 2024-03-01

Niedrigster Schlusskurs: $1.61 am 2007-10-01
Kursverlauf der Aktie von Avivagen Inc. von 2007 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2024 -10.52%
2023 -93.49%
2022 -74.40%
2021 -44.88%
2020 0.77%
2019 42.02%
2018 -56.32%
2017 -23.95%
2016 106.53%
2015 -27.79%
2014 0.24%
2013 6.70%
2012 8.82%
2011 -46.08%
2010 -40.28%
2009 20.90%
2008 -13.74%
2007 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$171.67 -
DE
$165.47 27.27%
DE
$36.27 22.59%
JP
$232.21 43.17%
CH
$21.32 13.71%
IN